Abstracts tagged "Ankylosing spondylitis (AS)"

Abstract Number: 570 • 2019 ACR/ARP Annual Meeting
Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up of Ankylosing Spondylitis (AS) Patients with a Rheumatologist-patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China
Jing Xue¹, Hui Song ², Hongzhi Wang ³, Jianlin Huang ⁴, Wenqiang Fan ⁵, Hua Wei ⁶, Hongbin Li ⁷, Weili Liu ⁸, Jin Zhang ⁹, Henglian Wu ¹⁰, Bei Wang ¹¹, Jianhua Xu ¹², Yan Huang ¹³, Hongjun Zhao ¹⁴, Zhiguo Wang ¹⁵, Zhiyong Huang ¹⁶, Xiaohong He ¹⁷, Wenhui Huang ¹⁸, Qiwen Ma ¹⁹, Bing Wu ²⁰, Yuhua Jia ²¹, Yuan Liu ²², Hui Xiao ²², Fei Xiao ²³ and Huaxiang Wu ¹, ¹The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (People's Republic), ²Beijing Jishuitan Hospital, Beijing, Beijing, China (People's Republic), ³JiaXing First Hospital, Jiaxing, Zhejiang, China (People's Republic), ⁴The sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China (People's Republic), ⁵Central Hospital of XinXiang, Xinxiang, Hainan, China (People's Republic), ⁶Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), ⁷The Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, Nei Mongol, China (People's Republic), ⁸Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China (People's Republic), ⁹[email protected], Ningbo, Zhejiang, China (People's Republic), ¹⁰Dongguan donghua hospital, Dongguan, Guangdong, China (People's Republic), ¹¹Beijing Hospital of Traditional Chinese Medicine, Beijing, Beijing, China (People's Republic), ¹²First Affiliated Hospital of Medical University Of Anhui, Hefei, Anhui, China (People's Republic), ¹³North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China (People's Republic), ¹⁴The First Xiangya Hospital of Central South University, Changsha, Hunan, China (People's Republic), ¹⁵Tangshan Gongren Hospital, Tangshan, Hebei, China (People's Republic), ¹⁶Huizhou First Hospital, Huizhou, Guangdong, China (People's Republic), ¹⁷Guangdong Province Traditional Chinese Medical Hospital, Guangzhou, Guangdong, China (People's Republic), ¹⁸The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China (People's Republic), ¹⁹The First People's Hospital of Foshan, Foshan, Guangdong, China (People's Republic), ²⁰Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), ²¹Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), ²²Shanghai Gothic Internet Technology Co., Ltd, Shanghai, Shanghai, China (People's Republic), ²³Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic)
Background/Purpose: Ankylosing Spondylitis Disease Activity Score (ASDAS) is adopted to evaluate the degree of disease activity and the inflammatory response in AS patients. ASDAS score ≤…
Abstract Number: 619 • 2019 ACR/ARP Annual Meeting
Relation of Therapies for Ankylosing Spondylitis to Risk of Total Hip and Knee Arthroplasty
Rachael Stovall¹, Christine Peloquin ², David Felson ³, Tuhina Neogi ² and Maureen Dubreuil ⁴, ¹Boston Medical Center, Boston, MA, ²Boston University School of Medicine, Boston, MA, ³Boston University School of Medicine, Department of Rheumatology, Boston, ⁴Boston University School of Medicine, Boston
Background/Purpose: Ankylosing spondylitis (AS) is an inflammatory arthritis that predominantly affects the axial skeleton, but commonly affects peripheral joints as well. Peripheral joint involvement often…
Abstract Number: 1505 • 2019 ACR/ARP Annual Meeting
Persistence with Etanercept in Patients with Ankylosing Spondylitis or Psoriatic Arthritis in Germany: A Real-World Analysis
Xenofon Baraliakos¹, Denis Poddubnyy ², Frank Behrens ³, Cinzia Curiale ⁴, Miriam Tarallo ⁴, Ana Cristina Hernandez Daly ⁵, Olaf Behmer ⁶, Joseph Cappelleri ⁷, Nicholas Hudson ⁸ and Christen Gray ⁸, ¹Rheumatology Department, Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, ²Charité - Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin, Germany, Berlin, Germany, ³Rheumatology Goethe-University Frankfurt & Fraunhofer IME-TMP, Frankfurt, Germany, ⁴Pfizer Inc., Rome, Italy, ⁵Pfizer Inc., Athens, Greece, ⁶Pfizer Inc., Berlin, Germany, ⁷Pfizer Inc, Groton, CT, ⁸IQVIA, London, United Kingdom
Background/Purpose: Ankylosing spondylitis (AS) and psoriatic arthritis (PsA) treatment includes biologics, prescribed on a long-term basis. As persistence data from real-world practice are limited, the…
Abstract Number: 2210 • 2019 ACR/ARP Annual Meeting
Relationship Between Structural Spine Involvement and the Scanographic Bone Attenuation Coefficient of L1 in a Population of 73 Patients with Ankylosing Spondylitis
Marine Fauny¹, Frank VERHOEVEN ², Edem Allado ¹, Eliane Albuisson ³, Caroline Morizot ¹, Astrid Pinzano-Watrin ⁴, Isabelle Chary-Valckenaere ³ and Damien Loeuille ⁵, ¹CHRU Nancy, VANDOEUVRE, France, ²CHU Besancon, BESANCON, France, ³Centre Hospitalier Universitaire de Nancy, VANDOEUVRE, France, ⁴IMoPA. UMR 7365 CNRS, Vandoeuvre, France, ⁵Rheumatology, Nancy University Hospital and and UMR 7365 CNRS-UL IMoPA, Université de Lorraine, VANDOEUVRE, France
Background/Purpose: Thoracic and/or thoraco-abdomino-pelvic (TAP) Computed Tomography (CT) may be performed during the follow up of patients with ankylosing spondylitis (AS) and are able to…
Abstract Number: L13 • 2018 ACR/ARHP Annual Meeting
Long-Term Evaluation of Secukinumab in Ankylosing Spondylitis: 5 Year Efficacy and Safety Results from a Phase 3 Trial
Xenofon Baraliakos¹, Jürgen Braun², Atul A. Deodhar³, Denis Poddubnyy⁴, Alan J. Kivitz⁵, Hasan Tahir⁶, Filip van Den Bosch⁷, Evie Maria Delicha⁸, Zsolt Talloczy⁹ and Anke Fierlinger⁹, ¹Rheumazentrum Ruhrgebiet, Herne, and Ruhr University Bochum, Herne, Germany, Herne, Germany, ²Rheumazentrum Ruhrgebiet Herne, and Ruhr University Bochum, Herne, Germany, Herne, Germany, ³Oregon Health & Science University, Portland, Portland, OR, ⁴Rheumatology, Campus Benjamin Franklin Charité – Universitätsmedizin, Germany and German Rheumatism Research Centre, Berlin, Germany, Berlin, Germany, ⁵Altoona Arthritis & Osteoporosis Center, Duncansville, PA, ⁶Whipps Cross University Hospital, Barts Health NHS Trust, London, United Kingdom, ⁷Rheumatology, Universitair Ziekenhuis, Ghent, Belgium, Gent, Belgium, ⁸Novartis Pharma AG, Basel, Basel, Switzerland, ⁹Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States, East Hanover, NJ
Background/Purpose: Clinical evaluation of efficacy and safety for long-term treatment for ankylosing spondylitis (AS) is important for treatment decision-making. Secukinumab (SEC), a fully human mAb…
Abstract Number: 285 • 2018 ACR/ARHP Annual Meeting
Inflammatory Bowel Disease Is Associated with a Substantial Economic Burden in Patients with Psoriatic Arthritis and in Patients with Ankylosing Spondylitis
Martin J. Bergman¹, Patrick Zueger², Jinlin Song³, Irina Pivneva⁴, Keith A. Betts³ and Avani D. Joshi⁵, ¹Drexel University College of Medicine, Philadelphia, PA, ²AbbVie Inc., North Chicago, IL, ³Analysis Group, Inc., Los Angeles, CA, ⁴Analysis Group, Inc., Montreal, QC, Canada, ⁵AbbVie, Inc., North Chicago, IL
Background/Purpose: Psoriatic arthritis (PsA) and ankylosing spondylitis (AS) belong to a group of inflammatory arthritides known to share similar extra-articular manifestations, such as inflammatory bowel…
Abstract Number: 691 • 2018 ACR/ARHP Annual Meeting
A Service Evaluation of Reporting Standards of Computer Tomography Defined Sacroiliitis Suggestive of Axial Spondyloarthritis in Inflammatory Bowel Disease Patients Imaged for Non-Musculoskeletal Indications
Chong Seng Edwin Lim¹, Samantha Bee Lian Low², Baljeet Dhillon², Shin Azegami², Andoni Paul Toms² and Karl Gaffney¹, ¹Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom, ²Radiology, Norfolk and Norwich University Hospital, Norwich, United Kingdom
Background/Purpose: A combined service evaluation by the rheumatology and radiology department was undertaken to understand the frequency and reporting standards of Computer Tomography-defined Sacroiliitis (CTSI)…
Abstract Number: 1623 • 2018 ACR/ARHP Annual Meeting
Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
James T. Rosenbaum¹, Lisa Pisenti², Yujin Park³ and Richard Howard⁴, ¹Ophthalmology, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, OR, ²UCB, Inc., Smyrna, GA, ³Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁴Spondylitis Association of America, Van Nuys, CA
Background/Purpose: While severe pain and stiffness are common hallmarks of ankylosing spondylitis (AS), disease progression is slow and not always visible; however, the quality of…
Abstract Number: 2396 • 2018 ACR/ARHP Annual Meeting
Reduction in the Utilization of Prednisone and/or Methotrexate Following the Initiation of Etanercept in Pediatric Patients
Majed M M Khraishi¹, Brad Millson², John Woolcott³, Lisa Marshall⁴ and Heather Jones⁴, ¹Memorial University of Newfoundland, St John's, NF, Canada, ²IQVIA, Kanata, ON, Canada, ³Global Outcomes & Evidence, Pfizer, Collegeville, PA, ⁴Pfizer, Collegeville, PA
Background/Purpose: In Canada, the pediatric indications of etanercept (ETN) are active ankylosing spondylitis (AS), plaque psoriasis (PsO) and moderate to severely active juvenile idiopathic arthritis…
Abstract Number: 311 • 2018 ACR/ARHP Annual Meeting
Magnetic Resonance Imaging of the Cervical Spine in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Presenting with Chronic Neck Pain – a Systematic Comparison of Clinical Assessments
Xenofon Baraliakos¹, Mina Soltani², Parham Damirchi², Uta Kiltz³ and Jürgen Braun¹, ¹Ruhr-University Bochum, Herne, Germany, ²Rheumazentrum Ruhrgebiet, Herne, Germany, ³Rheumatology, Rheumazentrum Ruhrgebiet, Herne, and Ruhr University Bochum, Herne, Germany
Background/Purpose: Despite the differences in pathogenesis, neck pain associated with functional limitation of the cervical spine is a frequent clinical symptom of patients with rheumatoid…
Abstract Number: 836 • 2018 ACR/ARHP Annual Meeting
Genetic Risk Score Prediction in Ankylosing Spondylitis
Zhixiu Li¹, Erika De Guzman¹, Jessica Harris¹, Nurullah Akkoc², Mahdi Mahmoudi³, Maxime Breban⁴, Chung-Tei Chou⁵, Michael Weisman⁶, Lianne S. Gensler⁷, Michael Ward⁸, Mohammad H. Rahbar⁹, Laura A. Diekman¹⁰, Tae-Hwan Kim¹¹, Paul Leo¹, John D. Reveille¹⁰, Paul Wordsworth¹², Matthew Brown¹ and Huji Xu¹³, ¹Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, ²Rheumatology, İzmir, Turkey, İzmir, Turkey, ³Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran (Islamic Republic of), ⁴Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne, France, Boulogne, France, ⁵Division of Allergy-Immunology-Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Taipei, Taiwan, ⁶Cedars-Sinai Medical Center, Los Angeles, CA, USA, Los Angeles, CA, ⁷University of California San Francisco, San Francisco, CA, ⁸National Institutes of Health, Bethesda, MD, USA, Bethesda, MD, ⁹Biostatistics/Epidemiology/Research Design (BERD) Core | Center for Clinical and Translational Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, USA, Houston, TX, ¹⁰Rheumatology, McGovern Medical School at the University of Texas Health Science Center at Houston, USA, Houston, TX, ¹¹Rheumatology, The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea, Seoul, Korea, Republic of (South), ¹²Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, Oxford, United Kingdom, ¹³School of Clinical Medicine, Tsinghua University, Beijing, China, Beijing, China
Background/Purpose: The diagnosis of ankylosing spondylitis (AS) is delayed by on average 8–11 years after the onset of symptoms, and there is increasing evidence that…
Abstract Number: 1624 • 2018 ACR/ARHP Annual Meeting
Real-World Insight into the Disease Burden and Treatment of Spondyloarthritis from a US-Based Life Impact Survey
James T. Rosenbaum¹, Lisa Pisenti², Yujin Park³ and Richard Howard⁴, ¹Ophthalmology, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, OR, ²UCB, Inc., Smyrna, GA, ³Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁴Spondylitis Association of America, Van Nuys, CA
Background/Purpose: Spondyloarthritis (SpA) is a group of chronic, inflammatory diseases associated with severe pain in the joints and entheses. There is limited evidence on real-world…
Abstract Number: 2430 • 2018 ACR/ARHP Annual Meeting
Pregnancy in Women with Ankylosing Spondylitis Is Not Associated with Poor Obstetric Outcomes: Analysis of Nationwide Inpatient Sample Database 2003-2011
Vikas Majithia and Shweta Kishore, Division of Rheumatology, University of Mississippi Medical Center, Jackson, MS
Background/Purpose: Outcomes of pregnancy are well studied in a number of rheumatic diseases such as Rheumatoid Arthritis (RA) and systemic lupus erythematosus. When compared, there…
Abstract Number: 316 • 2018 ACR/ARHP Annual Meeting
Eligibility Rates in Axial Spondyloarthritis Clinical Trials Based on Imaging Criteria
Farhan A. Syed¹, David Bennett¹, Michael O'Connor¹, Gabriele Pradella² and Sarah Warner¹, ¹Scientific and Medical Services, PAREXEL International, Billerica, MA, ²Image Management, PAREXEL International, Billerica, MA
Background/Purpose: Axial Spondyloarthritis (AxSpA) encompasses both non-radiographic (nr-AxSpA) as well as radiographic ankylosing spondylitis (AS) which displays structural changes at the sacro-iliac joint (SIJ). Phase…
Abstract Number: 892 • 2018 ACR/ARHP Annual Meeting
Establishing the Minimal Clinically Important Difference (MCID) for the Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL)
Nicolas Richard¹, Nigil Haroon², George Tomlinson³, Ismail Sari¹, Zahi Touma⁴ and Robert D Inman¹, ¹Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada, ²Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, Toronto, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: The Ankylosing Spondylitis Quality of Life (ASQoL) is a readable and simple to complete questionnaire relating to health-related quality of life (HRQoL) in subjects…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].